Analysis, article raise questions about Gardasil's safety

A safety analysis conducted by the FDA and the CDC links Merck & Co.'s cervical cancer vaccine Gardasil to 1,900 reports of fainting and 56 incidents of blood clots. Also, a medical article written by Columbia University researchers criticizes Merck's marketing strategy for the drug, saying it failed to address "the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits."

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN